Strategic Intelligence for Precision Medicine
Strategic market analytics: From vision to implementation
We don’t just project the future; we help execute it. We offer services tailored to the digital maturity of each organization.
Market analysis & insights
We evaluate diagnostic infrastructure, market dynamics, and trends by integrating the "voice of the expert"
Strategy implementation & playbooks
Design of actionable plans based on real-world analysis of local and global diagnostic infrastructure
Access & adoption advisory
Experts in digital and molecular pathology to guide entry into complex markets, ensuring full regulatory compliance
Why Circular-Lab?
- We add over 10 years leading Precision Medicine projects on a global scale.
- We understand real-world market challenges to ensure every strategy is actionable.
- We ensure that RWD (Real-World Data) projects meet the most demanding security and compliance standards.
Need a custom analysis? Let's take it to the next level
Ad-Hoc Intelligence: Custom insights in real-world settings
Some strategic questions require more than traditional market analysis. For specific challenges in access, diagnostics, and validation, we deploy our C-LAB® intelligence layer over real-world clinical environments to deliver answers with surgical precision.
Custom analytical solutions:
- Market hypothesis validation: We leverage our technology to test commercial or clinical assumptions against real-time structured data, eliminating uncertainty in new therapy launches.
- Targeted Real-World Evidence (RWE) Generation: We structure specific patient and biomarker cohorts for observational studies, ensuring clean, analysis-ready data in record time.
- Critical infrastructure audit: In-depth analysis of technical capacity in specific centers or regions (installed base, workflows, and turnaround times) to optimize your Market Access strategy.
- Biomarker deep-dive: Detailed tracking of testing and positivity rates in complex therapeutic niches.
How do we make it possible?
We combine our holistic sector vision with our proprietary AI platform, C-LAB®, allowing us to:
1
Access the data: Leveraging established project agreements with laboratories and hospitals.
2
Structure the complex: Transforming unstructured reports into actionable analytical variables.
3
Implement the solution: Delivering an execution playbook based on the laboratory’s operational reality.
Do you have a strategic question without an answer ?
Syndicated Report 2026: The DP-AI Adoption Journey in EU4+UK
The definitive strategic roadmap for Digital Pathology & AI in Europe
What you will discover:
- Installed base (scanners, IMS, AI).
- Adoption across segments and geography (Full DP labs vs Full DP-AI labs, academic vs regional centers, etc).
- Market size, growth forecasts, and competitive landscape.
- Feedback from the field (labs, pathologists, oncologists, institutions).
- Gaps and initiatives for reporting and monitoring Dx data.
- Main barriers and drivers to scaling DP-AI adoption.
- Expected trends up to 2030.
5 key market insights
Based on our proprietary research, the report dives deep into the trends redefining the sector:
1
Understanding the implementation gap between large academic hubs, private labs and regional laboratories
2
Why the focus is shifting from simple digitization to interoperable, structured data
3
How ADCs and Immuno-Oncology are skyrocketing demand for advanced analytics and computational pathology
4
Moving from clinical-phase pilot projects to tangible diagnostic benefits
5
Identifying the critical gaps in reporting and monitoring that hinder large-scale adoption
Beyond the report:
A strategic partnership
Every purchase includes a one-hour Q&A session with our Senior Analysts to address your team’s specific questions and strategic objectives.
Also, we offer modular customization to align the report with your specific goals (such as: extra slides or deeper analysis on specific countries / biomarkers / competitors, additional installed-base at lab-level, 1-1 meetings/workshops with KOLs / pathologists / oncologists to go deeper into field perception, center mappings, future needs for patient identification, larger market research / implementation strategy project…).
Pre-order the full report now to benefit from our Early Bird discount
and be among the first to receive these exclusive market insights upon publication.